For the past few decades, arbuscular mycorrhizal fungi have been applied as effective inoculants to enhance plant growth and productivity. The rhizosphere-inhabiting microorganisms which result in improvement of growth and protection of plant can be collectively defined as plant growth promoting microorganisms (PGPM). Plant growth promoting rhizobacteria (PGPR) improve plant growth and supports the plant to endure abiotic and biotic stresses. Plant growth
promoting fungi (PGPF) are known to colonize the region of the root of plants, and they enhance the plant nutrient uptake. The utilization of proper preparations of beneficial microorganisms is an inevitable demand to diminish the inputs of inorganic fertilizers, herbicides, and pesticides; moreover, it’s one of the most promising trends for sustainable agriculture and maintaining agricultural productivity. The production of strong inhibitory compounds by PGPF affects many plant pathogens. Fungi are omnipresent on organic compounds. The majority is saprobes and decomposes dead organic matter. Many excellent reviews about endophytic fungi in woody plants have already been published. However, only limited studies focused on the rhizosphere free living fungi efficacy for plant growth promotion. This review will consider the mode of actions of these fungi to better understand the promising contributions of PGPF in enhancing plant growth and protection.
A new series of 2-aminothiazole derivatives was designed and prepared as phosphodiesterase type 5 (PDE5) regulators and COX-1/COX-2 inhibitors. The screening of the synthesized compounds for PDE5 activity was carried out using sildenafil as a reference drug. Strikingly, compounds 23a and 23c were found to have a complete inhibitory effect on PDE5 (100%) at 10 μM without causing hypotension and the limited side effect of PDE5 inhibitors, suggest a distinctive therapeutic role of these derivatives in erectile dysfunction. On the other hand, compounds 5a, 17, 21 and 23b increased the PDE5 activity (PDE5 enhancers) at 10 μM. In addition, the study includes the screening of the COX-1/COX-2 inhibition induced by the synthesized compounds. All tested compounds have an inhibitory effect against COX-1 activity (IC50 = 1.00–6.34 μM range) and COX-2 activity (IC50 = 0.09–0.71 μM range). Moreover, a …
The arylhydrazones were treated with ethyl iodide, ethyl chloroacetate to afford the alkyl derivatives, which cyclized to the pyrazole derivatives, also, arylhydrazones were reacted with ethyl chloroformate to furnish the triazindione derivative. Reactions of arylhydrazones with hydroxylamine hydrochloride afforded the oxime derivative. Treatment of arylhydrazones with binucleophile reagents such as hydrazine hydrate and phenyl hydrazine gives the pyrazole derivatives. Treated of arylidine derivatives with malononitrile and hydrazine hydrate afforded the 4H-pyrane derivatives and pyrazole derivatives. The theoretical calculations optimization and frequency of synthesized compounds by Gaussian 09 with DFT by B3LYP method. The base set 6–31 G (d,p) to obtain descriptors explains the reactivity or stability of the synthesized compounds. It predicts the relation between theoretical descriptors computed which …
The elaboration of new small molecules that target phosphodiesterase enzymes (PDEs), especially those of type 5 (PDE5), is an interesting and emerging topic nowadays. A new series of heterocycle-based aminothiazoles were designed and synthesized from the key intermediate, 3-oxo-N-(thiazol-2-yl)butanamide (a PDE5 inhibitor that retains its amidic function), as an essential pharmacophoric moiety. The PDE5 inhibitors prevent the degradation of cyclic guanosine monophosphate, thereby causing severe hypotension as a marked side effect. Hence, an in vivo testing of the target compounds was conducted to verify its relation with arterial blood pressure. Utilizing sildenafil as the reference drug, Compounds 5, 10a, and 11b achieved 100% inhibitions of PDE5 without significantly lowering the mean arterial blood pressures (115.95 ± 2.91, 110.3 ± 2.84, and 78.3 ± 2.57, respectively). The molecular docking study revealed that the tested compounds exhibited docking poses that were similar to that of sildenafil (exploiting the amide functionality that interacted with GLN:817:A). The molecular shape and electrostatic similarity revealed a comparable physically achievable electrostatic potential with the reference drug, sildenafil. Therefore, these concomitant results revealed that the tested compounds exerted sildenafil-like inhibitory effects (although without its known drawbacks) on blood circulation, thus suggesting that the tested compounds might represent a cornerstone of beneficial drug candidates for the safe treatment for erectile dysfunction
The use of methotrexate (MTX), a classical immunosuppressant and anti-cancer agent, is associated with multiple organ toxicities, including the intestinal injury. Components of the renin-angiotensin system are expressed in the intestinal epithelium and mucosal immune cells where they provoke pro-inflammatory and pro-oxidant action. The present study was conducted to investigate the potential ability of perindopril (PER), an angiotensin-converting enzyme inhibitor (ACEI), to attenuate MTX-induced intestinal injury with emphasis on the role of the pro-inflammatory TLR4/NF-κB and c-Fos/c-Jun pathways alongside PPAR-γ and SIRT1 cytoprotective signals.
The intestinal injury was induced by a single-dose injection of 20 mg/kg of MTX i.p at the end of the 5th day. PER was administrated once daily in a dose of 1 mg/kg, i.p, for five days before MTX and five days later.
Herein, perindopril attenuated the intestinal injury as seen by lowering the histopathological aberrations and preserving the goblet cells in villi/crypts. These beneficial actions were associated with downregulating the expression of the pro-inflammatory angiotensin II and TNF-α, IL-1β, IL-6 cytokines, alongside upregulating the anti-inflammatory angiotensin (1–7) and IL-10. At the molecular level, perindopril downregulated the TLR4/NF-κB and c-Fos/c-Jun pathways in inflamed intestine of rats. Moreover, it attenuated the pro-oxidant events by lowering intestinal MDA and boosting GSH, SOD, and GGT antioxidants together with PPAR-γ and SIRT1 cytoprotective signals. The aforementioned findings were also highlighted using molecular docking and network pharmacology analysis.
Perindopril demonstrated notable mitigation of MTX-induced intestinal injury through suppression of TLR4/NF-κB and c-Fos/c-Jun pathways alongside the augmentation of PPAR-γ/SIRT1 cytoprotective signals.
We report here a considered novel study on the structural, FTIR spectra and optical properties of pure and co-doped Zn0.90-xFe0.1MxO with ((M=Cu, Ni and (x = 0.00, 0.10) & (0.00 < y < 0.20)) at different sintering temperatures Ts (Ts = 850 oC for series I and 1000 oC series II). Although the ZnO wurtzite structure is conformed for all samples, some secondary lines with little intensity are formed. But the number of these lines is higher for series I than for series II. The (c/a) value and U-parameter are almost constant for all samples, while Zn-O bond length L is slightly increased. The porosity and crystallite size are decreased by Fe, and also for (Fe+Cu) samples, and their values for series I are lower than for series II. The residual stress is tensile for most samples. Interestingly, the Young’s, rigid and bulk modulus, Poisson’s ratio and Debye temperature , obtained from FTIR analysis, are increased by Fe addition with a further increase for Fe+Ni) samples for both series. A ductile nature is obtained for pure, Fe and (Fe+Cu) samples; whereas a brittle nature is approved for (Fe+Ni) samples. On the other hand, the energy gap (Eg), residual lattice dielectric constant (εL) and carrier density N are increased by Fe addition, followed by a further increase for (Fe+Cu) samples, while the vice is versa for the inter-atomic distance R. For example, Eg was increased from 3.153 eV for pure ZnO to 3.974 eV for (Fe+Cu) samples (i.e. 0.821 eV more), while it was decreased to 2.851 eV for (Fe+Ni) samples (i.e. 0.302 eV less). A direct behavior is obtained between Eg and both elastic modulus (Y,β), lattice and micro strains (εL, εm), dislocation density (δ), residual stress (σ) and carrier density N, whereas a reverse behavior is obtained between Eg and both crystallite size (D), porosity (PS) and inter-atomic distance (R). These results are explained in terms of the generated blocked states of the conduction band as indicated by the Burstein Moss effect. These novel findings reveal that the co-doping has intense ZnO and moderate metal oxide modes in the ZnO matrix structure, which makes ZnO co-doped with (Fe+Cu) more suitable for gas sensors and optoelectronic devices. In contrast, ZnO co-doped with (Fe+Ni) samples is strongly recommended for altering plastic deformation. To our knowledge, the present investigation can be considered the first study and probably has never been discussed elsewhere, which highlights the present investigation.